
| 1958 |
| Simplex C Cement Introduced in Europe |
| 1962 |
| Simplex P Bone Cement Introduced in Europe |
| 1971 |
| Simplex P first to receive FDA approval in the U.S. for total hip arthroplasty. |
| 1973 |
| Simplex P Bone Cement approved for Total Knee Arthroplasty |
| 1975 |
| Simplex Antibiotic Bone Cement (with Erythromycin and Collistin) introduced in Europe |
| 1976 |
| Simplex P approved for pathological fractures and general prosthetic fixation |
| 1999 |
| Over 15 million doses of Simplex P have been implanted |
| 2000 |
| Simplex P with Tobramycin introduced in Europe |
| 2003 |
| Simplex P with Tobramycin introduced in U.S. |
| 2003 |
| Spineplex introduced in Europe |
| 2004 |
| SpinePlex introduced in U.S. |
OverviewVertaPlex has been developed for the physician desiring higher initial viscosity and longer working time. Great for multiple level vertebroplasties, VertaPlex maintains a desirable toothpaste-like consistency for an average of 18 minutes.
Designed and created by DDM Marketing & Communications.